SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-05-067229
Filing Date
2005-12-16
Accepted
2005-12-16 11:53:45
Documents
1
Period of Report
2005-12-14

Document Format Files

Seq Description Document Type Size
1 INITIAL ELECTION TO BOARD rrd99943.html 3  
1 INITIAL ELECTION TO BOARD rrd99943.xml 3 2058
  Complete submission text file 0001181431-05-067229.txt   3983
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2170 BUCKTHORNE PLACE SUITE 170 THE WOODLAND TX 77380
Business Address 2170 BUCKTHORNE PLACE SUITE 170 THE WOODLANDS TX 77380 7133679999
SUTTER MARTIN P (Reporting) CIK: 0001017832 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24274 | Film No.: 051268778